Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP660826.RA29tv9mAnJ-S9lIsTkSYHwVij9FoEn3CFAZ6fzqOiLfg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP660826.RA29tv9mAnJ-S9lIsTkSYHwVij9FoEn3CFAZ6fzqOiLfg130_assertion type Assertion NP660826.RA29tv9mAnJ-S9lIsTkSYHwVij9FoEn3CFAZ6fzqOiLfg130_head.
- NP660826.RA29tv9mAnJ-S9lIsTkSYHwVij9FoEn3CFAZ6fzqOiLfg130_assertion description "[Interest in ADAM12 has increased recently because its expression is related to tumor progression and it is a potential biomarker for breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660826.RA29tv9mAnJ-S9lIsTkSYHwVij9FoEn3CFAZ6fzqOiLfg130_provenance.
- NP660826.RA29tv9mAnJ-S9lIsTkSYHwVij9FoEn3CFAZ6fzqOiLfg130_assertion evidence source_evidence_literature NP660826.RA29tv9mAnJ-S9lIsTkSYHwVij9FoEn3CFAZ6fzqOiLfg130_provenance.
- NP660826.RA29tv9mAnJ-S9lIsTkSYHwVij9FoEn3CFAZ6fzqOiLfg130_assertion SIO_000772 18342566 NP660826.RA29tv9mAnJ-S9lIsTkSYHwVij9FoEn3CFAZ6fzqOiLfg130_provenance.
- NP660826.RA29tv9mAnJ-S9lIsTkSYHwVij9FoEn3CFAZ6fzqOiLfg130_assertion wasDerivedFrom befree-2016 NP660826.RA29tv9mAnJ-S9lIsTkSYHwVij9FoEn3CFAZ6fzqOiLfg130_provenance.
- NP660826.RA29tv9mAnJ-S9lIsTkSYHwVij9FoEn3CFAZ6fzqOiLfg130_assertion wasGeneratedBy ECO_0000203 NP660826.RA29tv9mAnJ-S9lIsTkSYHwVij9FoEn3CFAZ6fzqOiLfg130_provenance.